These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 5533415)

  • 1. [Desacetyl-lanatoside C: therapeutic effect in congestive heart failure].
    Tricot R; Urbanczyk A
    Ann Cardiol Angeiol (Paris); 1970; 19(4):373-83. PubMed ID: 5533415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of the use of desacetyl-lanatoside C in the treatment of cardiac insufficiency].
    Bersi M; Bocchiola M
    Minerva Cardioangiol; 1970 Jul; 18(7):449-56. PubMed ID: 5510027
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the advantages of the use of desacetyl-lanatoside C in cardiokinetic therapy].
    De Magistris L; Menegazzo G
    Minerva Med; 1967 Feb; 58(13):482-8. PubMed ID: 6021619
    [No Abstract]   [Full Text] [Related]  

  • 4. [The bradycardiac effect of oral administration of an overload of desacetyl-lanatoside C].
    Pavesi V; Bianchi G
    Minerva Med; 1966 Jun; 57(45):2075-8. PubMed ID: 5939220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Desacetyl-lanatoside-C in heart diseases].
    Apparete F; Pugliese F
    Minerva Cardioangiol; 1965 Oct; 13(10):692-6. PubMed ID: 5854401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with desacetyl-lanatoside C in treatment and in preparation for surgery of surgical heart disease patients].
    Stocco M; Grasso A
    Minerva Chir; 1965 Sep; 20(17):757-64. PubMed ID: 5852632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biometric study of the changes of the mechanical phases of the cardiac cycle induced by intravenous desacetyl-lanatoside C in normal humans].
    Sala G; Rocca E; Riva D; Foresti A
    Minerva Cardioangiol; 1967 Jun; 15(6):424-9. PubMed ID: 6056088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience on Desacetyl-lanatoside C].
    Fimiani R; Silvestroni A
    Minerva Cardioangiol; 1967 Mar; 15(5):353-7. PubMed ID: 5603841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infantile cardiac insufficiency of bronchopneumopathic origin. Treatment with desacetyl-lanatoside C].
    Negrini GP
    Minerva Pediatr; 1966 Sep; 18(28):1563-7. PubMed ID: 5994099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a single dose of lanatoside C on the left heart ventricle in patients with primary congestive cardiomyopathy].
    Dubiel JP; Cibor E
    Kardiol Pol; 1984; 27(5):385-91. PubMed ID: 6492562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation, by the polygraphic method, of the effect of proscillaridine A and desacetyl-lanatoside C in normal subjects].
    Jacono A; De Divitiis O; Vitale P; Giordano F
    Minerva Cardioangiol; 1967 Sep; 15(9):570-8. PubMed ID: 5629534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with desacetyl-lanatoside-C].
    De Lutterotti A
    Clin Ter; 1965 Aug; 34(4):300-7. PubMed ID: 5321635
    [No Abstract]   [Full Text] [Related]  

  • 13. [On some immediate effects of the intravenous administration of desacetyl-lanatoside C in aged subjects].
    Tàmmaro AE; Baldoli C
    Clin Ter; 1967 Jan; 40(2):157-61. PubMed ID: 5600177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of the maintenance dosage on urinary elimination of an average standard digitalization dose of tritiated desacetyl-lanatoside C in normal subjects and in fibrillating cardiopathic subjects].
    Damascelli B; Roncoroni L; Cova N; Pavesi V; Bianchi G
    Minerva Cardioangiol; 1967 Jun; 15(6):398-403. PubMed ID: 6056084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extracellular concentrations of potassium and fixation of tritium-labelled desacetyl-lanatoside C in isolated guinea pig heart].
    Marchetti G; Cerri O; Merlo L; Damascelli B; Bertoli MA
    Atti Soc Ital Cardiol; 1967; 2():189-91. PubMed ID: 5589564
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves.
    Ruel M; Rubens FD; Masters RG; Pipe AL; Bédard P; Hendry PJ; Lam BK; Burwash IG; Goldstein WG; Brais MP; Keon WJ; Mesana TG
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):149-59. PubMed ID: 14752425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular desacetyl lanatoside C: a safe and practical method of parenteral digitalization.
    ENSELBERG CD; DAVOODZADEH N; RIAHI H
    N Y State J Med; 1958 Dec; 58(24):4011-8. PubMed ID: 13613514
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.